// App-Quantinova.ai

TCT-830 : Outcomes of Patients With Elevated vs. Normal B-Type Natriuretic Peptides After Intervention for Left Main Coronary Artery Disease

Researchers

Presenter

  • Bjorn Redfors

Principal Investigators

  • Shmuel Chen

  • Aaron Crowley

  • Ori Ben-Yehuda

  • Bernard Gersh

  • Nicholas Lembo

  • William Brown

  • Adrian Banning

  • Patrick Serruys

  • A. Pieter Kappetein

  • Joseph Sabik

  • Gregg Stone

Medical Centers

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • Imperial College, London, United Kingdom

  • Mayo Clinic, Rochester, Minnesota, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York, United States

  • Columbia University, New York, New York, United States

  • Piedmont Heart Institute CardioThoracic Surgeons, Atlanta, Georgia, United States

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Cardiovascular Research Foundation, Queens, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

Locations

  • United Kingdom

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved